Literature DB >> 18582952

Behavioral and pathological outcomes in MOG 35-55 experimental autoimmune encephalomyelitis.

M V Jones1, T T Nguyen, C A Deboy, J W Griffin, K A Whartenby, D A Kerr, P A Calabresi.   

Abstract

We measured inflammatory and neural markers of disease from 7 days to one year after induction of experimental autoimmune encephalomyelitis (EAE) by immunization with myelin oligodendrocyte glycoprotein (MOG) peptide. Axon loss began before behavioral signs when T cell infiltration and microglial activation were very subtle. Remyelination was only detectable ultrastructurally. Axon numbers in the dorsal column plateau around day 30 p.i. while behavioral measures (EAE scores, rotarod, grip strength) partially recover. These results provide a starting point for testing potential neuroprotective treatments for multiple sclerosis (MS).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18582952     DOI: 10.1016/j.jneuroim.2008.05.013

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  41 in total

1.  Transfer of myelin-reactive th17 cells impairs endogenous remyelination in the central nervous system of cuprizone-fed mice.

Authors:  Emily G Baxi; Joseph DeBruin; Dominique M Tosi; Inna V Grishkan; Matthew D Smith; Leslie A Kirby; Hayley J Strasburger; Amanda N Fairchild; Peter A Calabresi; Anne R Gocke
Journal:  J Neurosci       Date:  2015-06-03       Impact factor: 6.167

2.  Aged hind-limb clasping experimental autoimmune encephalomyelitis models aspects of the neurodegenerative process seen in multiple sclerosis.

Authors:  Lindsay S Cahill; Monan Angela Zhang; Valeria Ramaglia; Heather Whetstone; Melika Pahlevan Sabbagh; Tae Joon Yi; Laura Woo; Thomas S Przybycien; Marina Moshkova; Fei Linda Zhao; Olga L Rojas; Josephine Gomes; Stefanie Kuerten; Jennifer L Gommerman; John G Sled; Shannon E Dunn
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-22       Impact factor: 11.205

3.  Neuronopathy in the motor neocortex in a chronic model of multiple sclerosis.

Authors:  Travis Burns; Laird Miers; Jie Xu; Alan Man; Monica Moreno; David Pleasure; Peter Bannerman
Journal:  J Neuropathol Exp Neurol       Date:  2014-04       Impact factor: 3.685

Review 4.  The development of myelin repair agents for treatment of multiple sclerosis: progress and challenges.

Authors:  Robert P Murphy; Keith J Murphy; Mark Pickering
Journal:  Bioengineered       Date:  2012-11-12       Impact factor: 3.269

5.  Conditional ablation of astroglial CCL2 suppresses CNS accumulation of M1 macrophages and preserves axons in mice with MOG peptide EAE.

Authors:  Monica Moreno; Peter Bannerman; Joyce Ma; Fuzheng Guo; Laird Miers; Athena M Soulika; David Pleasure
Journal:  J Neurosci       Date:  2014-06-11       Impact factor: 6.167

6.  Inhibition of glutamate carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis.

Authors:  Kristen A Rahn; Crystal C Watkins; Jesse Alt; Rana Rais; Marigo Stathis; Inna Grishkan; Ciprian M Crainiceau; Martin G Pomper; Camilo Rojas; Mikhail V Pletnikov; Peter A Calabresi; Jason Brandt; Peter B Barker; Barbara S Slusher; Adam I Kaplin
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-19       Impact factor: 11.205

7.  ICAM-1: isoforms and phenotypes.

Authors:  Theresa N Ramos; Daniel C Bullard; Scott R Barnum
Journal:  J Immunol       Date:  2014-05-15       Impact factor: 5.422

8.  Initiation and progression of axonopathy in experimental autoimmune encephalomyelitis.

Authors:  Athena M Soulika; Eunyoung Lee; Erica McCauley; Laird Miers; Peter Bannerman; David Pleasure
Journal:  J Neurosci       Date:  2009-11-25       Impact factor: 6.167

9.  Anti-IL-17A treatment reduces clinical score and VCAM-1 expression detected by in vivo magnetic resonance imaging in chronic relapsing EAE ABH mice.

Authors:  Silvy Mardiguian; Sébastien Serres; Emma Ladds; Sandra J Campbell; Panop Wilainam; Charles McFadyen; Martina McAteer; Robin P Choudhury; Paul Smith; Fay Saunders; Gillian Watt; Nicola R Sibson; Daniel C Anthony
Journal:  Am J Pathol       Date:  2013-04-16       Impact factor: 4.307

10.  Reactive astrocytes form scar-like perivascular barriers to leukocytes during adaptive immune inflammation of the CNS.

Authors:  Rhonda R Voskuhl; R Scott Peterson; Bingbing Song; Yan Ao; Laurie Beth J Morales; Seema Tiwari-Woodruff; Michael V Sofroniew
Journal:  J Neurosci       Date:  2009-09-16       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.